Fulcrum Therapeutics Stock Statistic Functions Beta

FULC Stock  USD 10.49  0.23  2.15%   
Fulcrum Therapeutics statistic functions tool provides the execution environment for running the Beta function and other technical functions against Fulcrum Therapeutics. Fulcrum Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Fulcrum Therapeutics statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Fulcrum Therapeutics correlated with the market. If Beta is less than 0 Fulcrum Therapeutics generally moves in the opposite direction as compared to the market. If Fulcrum Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fulcrum Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fulcrum Therapeutics is generally in the same direction as the market. If Beta > 1 Fulcrum Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Fulcrum Therapeutics Technical Analysis Modules

Most technical analysis of Fulcrum Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Fulcrum from various momentum indicators to cycle indicators. When you analyze Fulcrum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Fulcrum Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fulcrum Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fulcrum Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Fulcrum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fulcrum Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Fulcrum Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Fulcrum Therapeutics, we also check how macroeconomic factors affect Fulcrum Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 2025 2026 (projected)
Days Sales Outstanding292.6515.2513.7213.04
PTB Ratio1.761.21.381.31
Hype
Prediction
LowEstimatedHigh
2.7910.4918.19
Details
Intrinsic
Valuation
LowRealHigh
1.379.0716.77
Details
Naive
Forecast
LowNextHigh
3.6111.3119.00
Details
7 Analysts
Consensus
LowTargetHigh
17.3819.1021.20
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Fulcrum Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fulcrum Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fulcrum Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fulcrum Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulcrum Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Fulcrum Stock refer to our How to Trade Fulcrum Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Pharmaceuticals sector continue expanding? Could Fulcrum diversify its offerings? Factors like these will boost the valuation of Fulcrum Therapeutics. Market participants price Fulcrum higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fulcrum Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.14)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.21)
Return On Equity
(0.31)
The market value of Fulcrum Therapeutics is measured differently than its book value, which is the value of Fulcrum that is recorded on the company's balance sheet. Investors also form their own opinion of Fulcrum Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fulcrum Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Fulcrum Therapeutics' market value can be influenced by many factors that don't directly affect Fulcrum Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulcrum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulcrum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fulcrum Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.